Cardiovascular Metabolic Medical Science Liaison – Indiana

Amgen SA; Indianapolis (IN); Remote; USD 120,000 - 180,000; Full time

Benefits offered by this job

Competitive benefits

Total Rewards Plan

Stock-based incentives

Job summary

Amgen is seeking a Medical Science Liaison (MSL) for Cardiovascular Metabolic in Indiana. This field-based role interacts with cardiometabolic opinion leaders and healthcare decision-makers to communicate and advance Amgen's scientific platform aligned with corporate goals.

You will educate on clinical value, outcomes, and economic data, support payer discussions, and participate in cross-functional project teams to drive MSL strategies and tactics.

Qualifications

• Basic Qualifications include a Doctorate, or Master’s with 3+ years Medical Affairs experience, or Bachelor’s with 5+ years Medical Affairs experience.
• Preferred Qualifications include advanced degrees (PharmD/PhD/MD/DO) and 5+ years in Scientific or Medical Affairs at biotech/pharma companies.
• Experience focusing on cardio-metabolic areas and some clinical practice/research is valued.

Responsibilities

• Engage with cardiometabolic KOLs and healthcare decision-makers to communicate Amgen's scientific platform.
• Educate payers and providers on clinical value, outcomes, and economic data.
• Support payer, IDN, and formulary committee discussions and share insights with internal teams.

Skills

Medical affairs experience

Cardio-metabolic expertise

KOL engagement

Clinical data communication

Education

Doctorate degree

Master’s degree

Bachelor’s degree

Pharm. D./Ph.D./M.D./D.O.

Job description

Amgen is seeking a Medical Science Liaison (MSL) for Cardiovascular Metabolic in Indiana. This field-based role interacts with cardiometabolic opinion leaders and healthcare decision-makers to communicate and advance Amgen's scientific platform aligned with corporate goals.

You will educate on clinical value, outcomes, and economic data, support payer discussions, and participate in cross-functional project teams to drive MSL strategies and tactics.